Navigation Links
Global Pioneers in Patient Advocacy, Regulation and Research to Speak at DIA Meeting

Horsham, Pa (PRWEB) June 21, 2013

Ashley Appell, 26, has a rare disease that could kill her at age 30.

Appell and her fellow panelists at the DIA 2013 49th Annual Meeting, taking place June 23–27 in Boston, hold the power to help develop a drug that can save her and others with Hermansky-Pudlak syndrome.

The meeting, beginning on Monday at the Boston Convention & Exhibition Center, will include thousands of professionals from around the world representing all aspects of the drug and medical device industry—key innovators, patient advocates, drug regulatory officials, industry executives and esteemed researchers—to collaborate and advance therapies for patients like Appell.

“DIA is proud to bring these highly respected thought leaders and patient advocates to the table to address how to improve the development of much-needed therapies,” said Susan Cantrell, director of DIA North America. “The collaborative conversation among these key professionals and patients illustrates the power of the DIA 2013 49th Annual Meeting to drive improvement in all areas of the industry.”

Internationally acclaimed innovator Dr. Daniel Kraft will give the keynote address on Monday during the opening plenary session at 8:30 a.m. As the inventor of the MarrowMiner, an FDA-approved device for the minimally invasive harvesting of bone marrow, and founder of RegenMed Systems, a company developing technologies to enable adult stem-cell-based regenerative therapies, Kraft has extensive experience examining how technology trends will affect health and medicine.

On Monday at 10:15 a.m., Donna Appell will join her daughter, Ashley, on a panel of patient advocates selected for the DIA Patient Advocate Fellowship Program for their determined efforts to accelerate drug development and access. The panel also includes Steve Mikita, Utah’s assistant attorney general and a spinal muscular atrophy survivor, and Karen Ball, a patient advocate whose inspiring work with researchers helped to detect a genetic mutation that can result in Sturge-Weber syndrome, her daughter’s rare disease.

U.S. Food and Drug Administration Commissioner Margaret Hamburg will discuss collaboration among global drug regulatory agencies at Cooperation Among Regulators: Impact on Stakeholders on Monday at 2:30 p.m. Hamburg will be joined by Guido Rasi, European Medicines Agency executive director, and Paul Glover, assistant deputy minister of the Health Products and Food Branch at Health Canada.

Merck Executive Vice President and Chief Medical Officer Michael Rosenblatt, M.D., will provide the keynote address for a panel discussion on how big data may transform health care in Big Data: Impact on Innovation on Tuesday at 10:15 a.m. The discussion will help attendees from a wide range of global health industry sectors gain a greater sense of the impact big data has on their work, and learn how to effectively use big data to advance therapeutic innovation.

Harvard Medical School professors Dr. Rudy Tanzi, director of the Genetics and Aging Research Unit of the MassGeneral Institute for Neurodegenerative Disease, and Dr. Reisa Sperling, director of the Center for Alzheimer Research and Treatment at Brigham and Women’s Hospital, will join a panel of experts discussing collaboration to support the recent focus on genetic research for Alzheimer’s at Advancing Alzheimer’s Innovation: A Call to Action on Wednesday at 10:15 a.m.


ABOUT DIA: DIA is a neutral, global, professional and member-driven association of nearly 18,000 professionals involved in the discovery, development and life cycle management of pharmaceuticals, biotechnology, medical devices and related health care products. Through our international educational offerings and myriad networking opportunities, DIA provides a global forum for knowledge exchange that fosters the innovation of products, technologies and services to improve health and well-being worldwide. Headquarters are in Horsham, Pa., USA, with offices in Basel, Switzerland; Tokyo, Japan; Mumbai, India; Beijing, China; Washington, D.C.; and Latin America. Visit our website at and follow DIA at: LinkedIn, Twitter, YouTube, Facebook, Flickr and Pinterest.

Read the full story at

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Professional and Social Success Characterized the 2nd Global Conference by Dental Implants Leader MIS Implants Technologies Ltd.
2. David Icke to Launch Global TV and Radio Station Called The People's Voice
3. Research Suggests That Unhealthy Food Addiction Could Explain Global Obesity Epidemic
4. Global Youth Summit on The Future of Medicine-Shreya Rangarajan selected to represent Roland Park Country School and The State of Maryland
5. GHIT Fund celebrates historic beginning of Japanese R&D initiative in global health
6. One Million Babies Born HIV-free Signals Major Milestone in Global Effort to Eliminate Pediatric AIDS
7. UH Case Medical Center among first to enroll patients for global carotid artery trial
8. Global Medical Simulation Products & Services Market Growth Forecasts to 2017 in a New Research Report at
9. Global Radiopharmaceuticals Market Is Expected to Reach USD 12.2 Billion in 2018
10. Global Feed Additives Market Revenue to Reach $19.5 Billion in 2017, From $15,600.0 Million in 2011, at An Estimated CAGR of 3.8% - New Report by MarketsandMarkets
11. Global Proppant Market is Forecasted to Reach $7 Billion by 2017 From $4.3 Billion in 2012, at an Estimated CAGR OF 10.7% - New Report by MarketsandMarkets
Post Your Comments:
(Date:12/1/2015)... ... 2015 , ... CloudLIMS today announced that it is the ... the New Products and Services category for its innovative product offering, BioTracer. ... that helps labs organize data and track samples with storage inventories. BioTracer's SaaS ...
(Date:12/1/2015)... ... December 01, 2015 , ... ... must mark the film for accurate interpretation by the radiologist. The marking utensils ... inventor from Sacramento, Calif., has found a way to alleviate this problem. , ...
(Date:12/1/2015)... ... 2015 , ... McLean, VA., December 1, 2015 - Octo ... sprint agile development contract to support the National Geospatial-Intelligence Agency's (NGA) IT Services ... engineering, infrastructure, as well as operations and sustainment support to the NGA’s Agile ...
(Date:12/1/2015)... GA (PRWEB) , ... December 01, 2015 , ... ... supports SACC-GA and SACC-USA through membership and leadership since 2008. Gary ... Chair for SACC-USA . Gary has spent a significant amount of time ...
(Date:12/1/2015)... ... December 01, 2015 , ... ... Enterprise Authorized Technology Provider (ATP) status from Cisco. This designation recognizes Tympani as ... Cisco Unified Contact Center solutions targeted to the high-end enterprise contact center marketplace. ...
Breaking Medicine News(10 mins):
(Date:12/1/2015)... 1, 2015 Russia has always ... 70% of new drugs registered in Europe in ... --> Russia has always been a country ... drugs registered in Europe in 2015 were tested ... Russia has always been a country of choice ...
(Date:12/1/2015)... Dec. 1, 2015 Relmada Therapeutics, Inc. (OTCQB: RLMD), ... chronic pain, announced today that the company will present at ... December 1-3 at the Luxe Sunset Boulevard Hotel in ... CEO of Relmada Therapeutics, will present on Thursday, December 3, ... . Please register at least 10 minutes prior ...
(Date:12/1/2015)...   MabVax Therapeutics Holdings, Inc . (OTCQB: MBVX), ... filed an Investigational New Drug Application (IND) with the ... lead fully human antibody product HuMab 5B1 as a ... initiate the Phase I clinical trial early in 2016. ... The planned Phase I trial will evaluate the safety, ...
Breaking Medicine Technology: